Will Cronos Group shares return to the peak?
Cronos Group Inc. is a relatively minor cannabis producer. Its main activities include producing and selling both cannabis and hemp oil, which it markets under the brand name Peace Naturals. The company is licensed to sell cannabis for medical use and, beyond Canada, it is also active in the Australian and Israeli markets.
According to Cronos Group's own projections, the company's annual cannabis production will exceed 47 metric tons (51 US tons) by Q1 2019. In light of the legalization of the sale of cannabis for recreational use in Canada, Cronos Group has decided to open a chain of recreational dispensaries as part of a joint venture with American company MedMen.
In addition, Cronos Group has signed a 5-year exclusive distribution agreement with G. Pohl-Boskamp to supply its products to more than 12,000 pharmacies in Germany.
Recently, there has also been talk of a potential move by industry heavyweight Aurora Cannabis to acquire Cronos Group in a bid to increase its market share.
Cronos Group Inc. is listed on various stock exchanges, including the NASDAQ, under the ticker symbol CRON. Its share price currently stands at around $8.8, with market capitalization of approximately $1.5 billion. Stocks across the sector saw a sharp uptick following Canada's legalization of cannabis for recreational use in June of this year and Cronos Group's shares were no exception. They hit their peak of $13.75 per share on September 20, which was then followed by a gradual downward slide that continues to this day.
Not financial advice. The content of this article is provided by Libertex for general information and educational purposes only. It does not constitute investment advice, investment research, a personal recommendation, or an offer or solicitation to buy or sell any financial instrument or other asset. It is general in nature and is not tailored to any individual reader, so it cannot account for your personal circumstances, financial situation, knowledge, experience, or investment objectives. Any decision to act on this content is taken at your own discretion and risk, and you remain solely responsible for assessing whether a product or strategy is right for you and for seeking independent professional advice where appropriate.
Risk warning. Trading in financial instruments and other assets, particularly leveraged products such as CFDs, is complex and carries a high risk of losing money rapidly. Leverage magnifies both gains and losses, so small market movements can lead to disproportionate losses. The value of the assets referenced may rise or fall, and you may lose your entire invested amount. Past performance is not a reliable indicator of future results. The use of artificial intelligence, algorithms, automated strategies, or any other analytical tool in trading does not guarantee any particular outcome, does not eliminate risk, and does not replace your own judgement — you remain fully responsible for assessing every instrument, strategy, and decision, and for the results of your trading.
Why trade with Libertex?
- Get access to a demo account free of charge
- Receive live technical assistance 5 days a week, 24 hours a day
- Enjoy leverage of up to 1:500
- Use a platform for any device: Libertex and MetaTrader 4 and 5
- Pay zero commission on withdrawals in Latin America
- Benefit from up to $500 protection on your first trades with Negative Trade Protection